# A Trial of CMNa Combined With Definitive Concurrent Chemoradiotherapy for Locally Advanced ESCC

> **NCT02721563** · PHASE4 · COMPLETED · sponsor: **Shandong Cancer Hospital and Institute** · enrollment: 77 (actual)

## Conditions studied

- Esophageal Neoplasms

## Interventions

- **DRUG:** Sodium Glycididazole
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02721563
- **Lead sponsor:** Shandong Cancer Hospital and Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02-25
- **Primary completion:** 2018-06-10
- **Final completion:** 2018-06-30
- **Target enrollment:** 77 (ACTUAL)
- **Last updated:** 2019-10-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02721563

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02721563, "A Trial of CMNa Combined With Definitive Concurrent Chemoradiotherapy for Locally Advanced ESCC". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02721563. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*